From a pathogenic point of view, OPN is involved in invasion and dissemination of CNS lymphomas through activation of NF-κB, an effect mediated by both iOPN (transcriptional downregulation of NF-κB inhibitors) and sOPN (receptor-mediated activation of NF-κB). The gene discussed is NFKB1; the disease is primary central nervous system lymphoma.